Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for diabetes and weight loss.
Strategy and bitcoin-buying firms face wider exclusion from stock indexes
...
Read moreDetailsHome » GLP-1 pill shows success for diabetes, weight loss, Eli Lilly says
Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for diabetes and weight loss.